Euploid Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Bangalore, Karnataka, India, established in 2015.
2015 Bangalore, Karnataka, India Active
Last Updated:
Access Report
About Euploid Pharmaceuticals Private Limited

Euploid Pharmaceuticals Private Limited, a active private limited company, was established on 04 August 2015 in Bangalore, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230KA2015PTC081999. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹12.00 Cr and a paid-up capital of ₹6.00 Cr.

It upholds a compliant status. Its leadership includes Raju Chowdappa Raghavendra (Director), Nagarani (Director). Past directors included Muniswamaiah Krishnamurthy, Nagarani, Hanumappa Chowdappa. It holds ₹20.00 Cr open charges and ₹15.18 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 29/2, No 15, Vinayaka Layout, K R Puram, Bangalore, Karnataka, 560049.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230KA2015PTC081999

  • Registration Number

    081999

  • Incorporation Date

    04 August 2015

  • Authorized Capital

    ₹12.00 Cr

  • Paid-Up Capital

    ₹6.00 Cr

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 12.00 Cr
  • Paid Up Capital ₹ 6.00 Cr
  • Company Age 10 Year, 6 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 20.00 Cr
  • Satisfied Charges ₹ 15.18 Cr
  • Revenue Growth **** -26.52%
  • Profit Growth **** -653.08%
  • Ebitda **** -401.83%
  • Net Worth -17.10%
  • Total Assets **** 52.23%
Company report

Euploid Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Euploid Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Euploid Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Raju Chowdappa Raghavendra Director 04 Aug 2015 Current
Nagarani Director 04 Jun 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 20 May 2020 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past
Pramod Abcsdd Additional Director 31 Dec 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Euploid Pharmaceuticals.

Euploid Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 26.52% decrease. The company also saw a substantial fall in profitability, with a 653.08% decrease in profit. The company's net worth observed a substantial decline by a decrease of 17.1%.

Euploid Pharmaceuticals revenue growth over time
Euploid Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -26.52%
*******
*******
*******
*******
Revenue from Operations
*******
 -27.52%
*******
*******
*******
*******
Total Assets
*******
 52.23%
*******
*******
*******
*******
Profit or Loss
*******
 -653.08%
*******
*******
*******
*******
Net Worth
*******
 -17.10%
*******
*******
*******
*******
EBITDA
*******
 -401.83%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Euploid Pharmaceuticals?

In 2024, Euploid Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹200,000,000.00

Satisfied Charges

₹151,800,000.00

Charges Breakdown by Lending Institutions
  • City Union Bank Limited : 20.00 Cr
Latest Charge Details
Date Lender Amount Status
01 Jul 2025 City Union Bank Limited ₹20.00 Cr Open
16 Feb 2022 Canara Bank ₹15.18 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Euploid Pharmaceuticals?

Euploid Pharmaceuticals has a workforce of 0 employees as of Dec 17, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Euploid Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Euploid Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Euploid Pharmaceuticals
Recent Activity within the Organization
  • Charges

    The activity A charge registered on 16 Feb 2022 via Charge ID 100570819 with Canara Bank was fully satisfied on 10 Jul 2025. was completed.

  • Charges

    Progress on A charge with City Union Bank Limited amounted to Rs. 20.00 Cr with Charge ID 101129620 was registered on 01 Jul 2025. was documented.

  • Annual General Meeting

    Euploid Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Director Appointment

    Nagarani was appointed as a Director was appointed as a Director on 04 Jun 2024 & has been associated with this company since 1 year 8 months . was recorded as a recent event.

  • Balance Sheet

    Euploid Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was recorded as a recent event.

  • Charges

    The activity A charge with Canara Bank of Rs. 15.18 Cr registered on 16 Feb 2022 with Charge ID 100570819 was modified on 28 Dec 2023. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Euploid Pharmaceuticals Private Limited?

The CIN of Euploid Pharmaceuticals Private Limited is U24230KA2015PTC081999.

Where is Euploid Pharmaceuticals Private Limited headquartered?

Euploid Pharmaceuticals Private Limited is headquartered at 29/2, No 15, Vinayaka Layout, K R Puram, Bangalore, Karnataka, 560049.

When was Euploid Pharmaceuticals Private Limited incorporated?

Euploid Pharmaceuticals Private Limited was incorporated on 04 August 2015.

Who are the current directors of Euploid Pharmaceuticals Private Limited?

The current directors of Euploid Pharmaceuticals Private Limited are

What is the primary industry of Euploid Pharmaceuticals Private Limited?

The primary industry of Euploid Pharmaceuticals Private Limited is Manufacturing.

Is Euploid Pharmaceuticals Private Limited a listed company?

Euploid Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Euploid Pharmaceuticals Private Limited?

The authorized capital of Euploid Pharmaceuticals Private Limited is ₹12.00 Cr, and the paid-up capital is ₹6.00 Cr.

What is the compliance status of Euploid Pharmaceuticals Private Limited?

The compliance status of Euploid Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available